Thus, inhibition of ABCB1 alongside chemotherapy may be of benefit to all patients, by increasing drug uptake as well as rendering previously therapy-resistant tumours sensitive to ABCB1 substrates. The gene discussed is ABCB1; the disease is neoplasm.